<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-vaccines-07-00070">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Freed</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Meng</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Finnefrock</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Durr</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2013</year>
  <volume>110</volume>
  <fpage>E4997</fpage>
  <lpage>E5005</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1316517110</pub-id>
  <pub-id pub-id-type="pmid">24297878</pub-id>
 </element-citation>
</ref>
